On 2 December 2021, Sindusfarma and BNCC co-sponsored the webinar “Business Opportunities and ESG practices in the pharmaceutical markets in Brazil and Norway.”

The event was opened by Mr Nelson Mussolini, president of Sindusfarma and Mr Aage Thoen, president of the Brazilian Norwegian Chamber of Commerce. After that, Mrs Celma R Hellebust spoke about BNCC’s areas of interests and how to do business in Norway. The second panelist was Mr Walker Lahmann from Eurofarma, who covered the challenges and opportunities in the Brazilian pharmaceutical market.

The next panelist was Mr Bruno Porto, from PwC, who shared some thoughts about diversity and inclusion – ESG and the Brazilian experience – together with Mr Kleber Carvalho’s testimony of Bayer’s experience within ESG. Mr Jens Jakob Kjos-Hansen, from GE Healthcare, closed the event talking about ESG: a roadmap for a sustainable future.

230 people registered for this webinar, which was well attended.

The core of the presentations and the following debate were of a high level and showed that it is advantageous to invest in ESG, especially on its environmental perspective.

Below you can watch the full video of the event: